Arkolith/Insider Trading/CPRX/Form 4

Kalb Michael Wayne

Chief Financial OfficerCATALYST PHARMACEUTICALS, INC. (CPRX) · full profile →Form 4 · filed Jul 17, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
7
1 non-derivative · 6 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 15, 2026Disposed to issuer(D)14K$31.50$430K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 15, 2026Disposed to issuer(D)257K—$00
Jul 15, 2026Disposed to issuer(D)169K—$00
Jul 15, 2026Disposed to issuer(D)132K—$00
Jul 15, 2026Disposed to issuer(D)21K—$00
Jul 15, 2026Disposed to issuer(D)14K—$00
Jul 15, 2026Disposed to issuer(D)40K—$00

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001161697-26-000178) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML